Cancer specific Health Companions collect validated Patient Reported Outcomes Measures (PROMs) from patients outside routine clinical practice. Allowing patients to take control in the management of their cancer by enabling them to record, monitor and communicate how they feel. To support improvements in healthcare services, patient outcomes and research into new medicines.
The Digital Assessment Xchange (DAX) has been developed as a mechanism for continuous research into validated Patient Reported Outcomes Measures (PROMs). By linking into national medical records, ‘unique’ real-world studies can be undertaken to provide cost efficient, timely & precise evidence for the reimbursement and regulatory approval of new medicines.
DaSH Global partners with pharmaceutical companies to provide fully anonymised access to DAX data and national medical records through Public Health. Delivering 'protocol approved' real-world research studies with full analytical services.
DaSH Global look to enhance the drug approval process through the power of delivering cost-efficient, timely and precise evidence from unique real-world research methodologies.
Specialising in MedTech strategies & products through our vision of building collaborative ‘disruptive’ transformational research platforms from ‘joined up’ health care.
"Disruptive digital technology sounded good!? But now I’ve got my head around all the benefits this service has for our patients, nurses, and the charity, this is a real game changer".
Head of Services Mesothelioma UK
Liz Darlison MBE EN RN BSc MSc